NeuroStar TMS Therapy Explained: A Safe and Effective Choice

Understanding NeuroStar TMS therapy

If you are living with major depressive disorder and have tried multiple antidepressants without lasting relief, you are not alone. NeuroStar TMS therapy is a noninvasive brain stimulation treatment specifically designed for people whose depression has not responded to standard care. It targets the brain circuits involved in mood, without surgery, anesthesia, or systemic medication side effects.

NeuroStar is a form of repetitive transcranial magnetic stimulation, or rTMS, that uses focused magnetic pulses to stimulate areas of the brain that show decreased activity in depression. The FDA has cleared rTMS, including NeuroStar, for adults with major depression who did not improve adequately with antidepressants, and for some additional conditions such as OCD and anxious depression [1].

If you are comparing tms vs antidepressants or searching for a non medication treatment for depression, understanding how NeuroStar TMS therapy works and what to expect can help you decide if it fits into your treatment plan.

What treatment resistant depression means for you

You might wonder if your depression is really “treatment resistant” or if you simply have not found the right medication yet. In clinical practice, treatment resistant depression usually refers to major depressive disorder that has not improved sufficiently after trying at least two antidepressants at adequate dose and duration.

You may recognize treatment resistance if you have experienced some of the following despite consistent treatment:

Multiple antidepressant trials with only partial or temporary benefit
Side effects that forced you to stop or change medications
Persistent symptoms such as low mood, loss of interest, fatigue, or hopelessness
Ongoing functional impairment at work, in school, or in relationships

Real world data show that once several antidepressants have failed, the odds of full remission with yet another medication drop to under 7 percent [2]. If that pattern sounds familiar, you are exactly the type of person NeuroStar TMS therapy was designed to help. You can learn more about this diagnosis and care pathway in our tms for treatment resistant depression and treatment resistant depression program resources.

How NeuroStar TMS therapy works

NeuroStar TMS therapy uses magnetic energy to influence electrical activity in specific brain regions that regulate mood. The technology is similar in type and strength to magnetic fields used in MRI scanners, which have been in widespread global use for decades without evidence of brain tumors or memory loss [3].

Targeting mood regulation circuits

During a NeuroStar session, an electromagnetic coil is positioned gently against your scalp, usually over the left prefrontal cortex. This region is a key hub in the network that supports mood, motivation, decision making, and emotional regulation. In depression, activity in this area often becomes abnormally low.

The device delivers brief, repetitive magnetic pulses. These pulses painlessly pass through the skull and induce small electrical currents in the brain tissue underneath. Over time, the repeated stimulation can:

Increase activity in underactive synapses
Support healthier patterns of connectivity across mood circuits
Promote neuroplasticity, the brain’s capacity to form new, more adaptive connections [4]

NeuroStar describes this process as “waking up” underactive brain regions so that your mood regulation system can function more normally [2]. This mechanism is different from medication, which typically alters neurotransmitter levels throughout the brain and body.

Session length and treatment course

NeuroStar TMS therapy is an outpatient procedure that does not require anesthesia. You are awake, seated in a chair, and can speak with the clinician at any point. A typical course includes:

A first visit of about 60 minutes to map and personalize coil placement and dose
Daily sessions, usually 5 days per week, for 4 to 6 weeks
Individual sessions of about 19 to 40 minutes depending on the exact protocol [5]

Because there is no sedation, you can drive yourself to and from appointments and return to normal activities immediately afterward. This flexibility makes NeuroStar compatible with work, school, parenting, and other responsibilities.

For a broader view of where TMS fits within advanced depression treatment options, you can also review our overview of brain stimulation therapy for depression.

When NeuroStar TMS therapy is recommended

NeuroStar is not a first line treatment for depression. It is specifically intended for people who have not achieved satisfactory improvement from previous antidepressant medications or who cannot tolerate them.

According to its indication:

NeuroStar Advanced Therapy is approved for adults with major depressive disorder who have not improved adequately with prior antidepressant medications
It is also cleared as adjunctive therapy for adults with obsessive compulsive disorder and for adolescents aged 15 to 21 with MDD, in conjunction with medication [6]

If your depression is not responding to medication, a psychiatrist can evaluate whether you meet tms therapy eligibility criteria. In general, you may be a candidate if:

You have a confirmed diagnosis of major depressive disorder
You have tried at least one or more antidepressants at adequate dose and duration
You are not currently experiencing psychosis, active substance withdrawal, or severe mania
You do not have certain types of metal implants in or near the head, as described below

A psychiatrist supervised tms therapy program ensures that your overall treatment plan, including medications and psychotherapy, is adjusted thoughtfully as TMS progresses.

Safety, side effects, and contraindications

Safety is one of the main reasons many people consider NeuroStar TMS therapy as an alternative or addition to medications. Clinical trials and real world studies involving thousands of patients and hundreds of thousands of sessions have demonstrated a favorable safety profile [7].

Common and usually mild side effects

Most people tolerate NeuroStar well. In clinical trials of NeuroStar Advanced Therapy:

Fewer than 5 percent of people discontinued treatment because of adverse events
The most common side effect was temporary pain or discomfort at or near the treatment site, generally improving within the first week [8]

Other side effects occurring in at least 5 percent of patients and at twice the rate of placebo included:

Headache
Eye pain
Toothache
Muscle twitch
Facial pain
Skin pain near the site of stimulation [9]

These effects are usually mild to moderate and tend to lessen as your brain becomes accustomed to stimulation. Unlike electroconvulsive therapy, TMS does not require anesthesia, does not cause seizures as part of treatment, and has not been shown to cause memory loss [10].

Seizure risk and rare complications

There is a rare risk of seizure with TMS. For NeuroStar:

Clinical data suggest a seizure risk of less than 0.1 percent of patients
In a large review of more than 8,000 patients and 250,000 treatment sessions, seven seizures were reported, which corresponds to about 0.003 percent per treatment and 0.1 percent per patient. This is comparable to, or lower than, seizure risk associated with many antidepressant medications [11]

Because of this rare risk, careful screening is essential. TMS should be used with caution if you have a medical or genetic history that increases seizure risk [3]. Certain medications, such as antipsychotics or tricyclic antidepressants, can also raise seizure risk when combined with TMS, which is why coordinated psychiatric supervision is important.

Contraindications and metal implants

NeuroStar TMS therapy is contraindicated if you have conductive, ferromagnetic, or other magnetically sensitive metal implanted in your head or within about 30 centimeters of the treatment coil. Examples include:

Cochlear implants
Aneurysm clips
Deep brain stimulators
Vagus nerve stimulators
Bullet fragments or shrapnel in or near the head

In these situations, magnetic stimulation could cause movement or heating of the implant, which may lead to serious injury or death [12]. Dental fillings and most devices located below the neck are typically not a problem, but your care team will review your full medical and surgical history.

Interactions with medications

You should inform your treating psychiatrist about all current medications. Issues to consider include:

Bupropion (Wellbutrin) may increase the risk of tinnitus during TMS
Antipsychotics and tricyclic antidepressants can increase seizure risk when combined with TMS
Dosage adjustments might be recommended in some cases [3]

Close monitoring by a psychiatrist allows your TMS protocol and medication regimen to be adjusted safely throughout treatment.

What you can expect during treatment

Knowing what will actually happen at each visit can reduce anxiety and help you prepare. A typical NeuroStar treatment plan involves several distinct phases.

Initial evaluation and mapping

Before you begin, you will meet with a psychiatrist or TMS specialist to:

Confirm your diagnosis of major depressive disorder
Review your history of medications, psychotherapy, and other treatments
Screen for contraindications such as incompatible implants or seizure risk
Discuss your goals, schedule, and preferences

On your first TMS session, the clinician will perform “motor threshold” mapping. This process identifies the minimum magnetic strength that causes a small movement of your thumb or fingers. That measurement helps determine your personal stimulation dose and coil position. The mapping and initial treatment typically take about an hour [13].

Daily sessions

During each session:

You sit in a comfortable chair
The TMS coil is positioned against your scalp
You may hear clicking sounds and feel tapping or tingling on your head where the coil is placed
You remain awake and can pause the procedure if needed

Many people bring headphones or practice relaxation strategies during treatment. Over time, the sensation usually becomes more familiar and less bothersome.

Because there is no sedation and no recovery period, you can return to work, drive, or resume your day right after each visit. This outpatient format supports continuity of your daily life while you receive intensive care.

Integrating TMS with psychotherapy and medication

NeuroStar TMS therapy is most effective when it is integrated into a comprehensive treatment plan rather than used in isolation. That plan often includes:

Ongoing psychiatric follow up to monitor mood, adjust medications, and track progress
Individual or group psychotherapy to strengthen coping skills, address thought patterns, and build behavioral change
Lifestyle interventions such as sleep hygiene, exercise, and social connection

Some programs offer an integrated tms and psychotherapy program in which therapy sessions are scheduled around or even during the TMS course, capitalizing on improved brain plasticity to enhance learning and emotional processing.

Effectiveness and expected outcomes

When you are making a commitment of daily visits for several weeks, it is reasonable to ask, “How effective is NeuroStar TMS therapy really, and how does it compare to my other options?”

Clinical trials and real world results

A number of studies and registries have evaluated NeuroStar and other TMS systems in people with treatment resistant depression.

Key findings include:

In NeuroStar clinical data, 83 percent of patients who completed a full treatment cycle experienced measurable relief in depression symptoms
Approximately 62 percent achieved remission, meaning that if they were evaluated after treatment, they would likely no longer meet criteria for major depressive disorder
These improvements have been shown to last at least 12 months in many patients, especially when appropriate follow up care is in place [14]

Independent research on rTMS has shown similarly meaningful effects. For example:

A large multicenter randomized controlled trial found that rTMS as drug free monotherapy produced remission rates about four times higher than sham treatment [7]
Observational studies from university based clinics reported remission rates between about 25 and 35 percent in highly treatment resistant patients, many of whom had already undergone electroconvulsive therapy [7]
At three months, 58 percent of people who had remitted with TMS remained in remission [7]

Other analyses have reported that around half of people with treatment resistant depression experience major improvement and about one third achieve full remission with NeuroStar TMS Therapy, with symptom relief sustained for at least 12 months in many cases [4].

You can explore more about how effective is tms for depression and typical tms therapy success rate in our dedicated articles.

Comparing TMS with additional medication trials

For individuals who have already tried several antidepressants without adequate response, each subsequent medication offers diminishing returns. For example, after multiple failed trials, the chance of remission with another pharmacologic approach falls below 7 percent [2].

NeuroStar TMS therapy offers:

A different mechanism that directly targets mood regulation circuits, not just neurotransmitter levels
A favorable side effect profile without systemic weight gain, sexual dysfunction, or gastrointestinal issues
A noninvasive, outpatient format without anesthesia or recovery time

This does not mean medication has no role. Many people continue on stable antidepressant regimens while receiving TMS, or transition to a simpler or lower dose regimen once their mood improves. The goal is to construct a personalized plan that balances effectiveness, tolerability, and your own preferences.

If you are actively weighing tms vs antidepressants, discussing these comparative response rates and side effect burdens with your psychiatrist can be very helpful.

Insurance coverage and cost considerations

Cost is often a practical concern when you are considering an advanced treatment like NeuroStar. The good news is that:

Most major health insurance plans in the United States now cover TMS for major depressive disorder when certain criteria are met
Insurers usually require documentation that you have tried and not responded adequately to a specified number of antidepressants and, in some cases, a course of psychotherapy [13]

From a health economics perspective, NeuroStar TMS therapy has demonstrated favorable value compared with antidepressant medication for both patients and insurers, even for people who had already failed prior treatment attempts [3].

Your care team can help you:

Verify benefits and prior authorization requirements
Estimate out of pocket costs based on your deductible and copays
Explore payment plans if you are paying partly or fully out of pocket

You can find more details on typical coverage patterns in our guide to insurance coverage for tms therapy.

Deciding if NeuroStar TMS therapy is right for you

Choosing to pursue NeuroStar TMS therapy is a personal decision. It often feels most appropriate when:

You have a clear history of inadequate response or intolerance to multiple antidepressants
Your depressive symptoms remain significantly impairing despite treatment
You prefer to limit further medication changes or are seeking a more targeted, brain based intervention
You are willing and able to commit to frequent outpatient visits for several weeks

If these points resonate with you, the next step is usually a consultation with a psychiatrist who has experience providing tms therapy for major depressive disorder. In that setting you can:

Review your full treatment history
Clarify your goals and concerns
Learn exactly how NeuroStar would be tailored to your clinical picture
Discuss how it would integrate with therapy, medication, and broader advanced depression treatment options

NeuroStar TMS therapy is not a cure for everyone, but for many people with treatment resistant depression it offers a realistic path to meaningful relief and, in some cases, full remission. In a landscape where further medication trials offer progressively lower odds of success, exploring a neuroscience-driven, noninvasive option like TMS can be a rational and hope restoring step toward recovery.